To access the full text documents, please follow this link: http://hdl.handle.net/2445/46026

Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell function
Llaudó Vallmajor, Inés; Cassis, L.; Torras Ambròs, Joan; Bestard Matamoros, Oriol; Franquesa, M.; Cruzado, Josep Ma.; Cerezo, G.; Castaño Boldú, Esther; Pétriz, J.; Herrero Fresneda, Immaculada; Grinyo Boira, Josep M.; Lloberas Blanch, Núria
Universitat de Barcelona
Purpose. P-glycoprotein (Pgp) is a member of the ABC-transporter family that transports substances across cellular membranes acting as an efflux pump extruding drugs out of the cells. Pgp plays a key role on the pharmacokinetics of several dr ugs. Herein, we have studied the effects of immunosuppressants on Pgp function, assessing rhodamine-123 (Rho123) uptake and efflux in different T- cell subsets. Methods. Different immunosuppressants such as Cyclosporine (CsA), Rapamycin (Rapa) and Tacrolimus (Tac) were used to assess the in vitro effect on Pgp function of main T-cell subsets among healthy volunteers. We measured Rho123 upta ke, efflux and kinetic of extrusion in CD4 + and CD8 + subsets by flow cytometry. Antigen-specific memory T-ce ll responses were assessed by measuring T-cell proliferation and cytokine secretion using an allogeneic mixed lymphocyte reaction. Results. Rho123 uptake in groups treated with CsA and CsA+Rapa was signif icantly decreased compared to non-treated group and the other immunosupressants in both T cells subsets. Pgp activity was also reduced in CsA and CsA+Rapa compared to the other immunosupressants but it was only significant in the CsA group for CD8 + subset. Kinetic extrusion of Rho123 by Pgp in all groups was faster in CD8 + T cells. All immunosuppressants and the specific Pgp inhibitor PSC833 diminished antigen-primed T-cell proliferation, especially CD8 + T-cell subset. Conclusions. Our data indicate that small molecules immunosuppressants, especially CsA, inhibit Pgp activity and T-cell function being the CD8 + T cells more susceptible to this effect. These findings support the importance of Pgp when designing combined immunosuppressive regimens.
Immunosupressió
Transport biològic
Proteïnes de membrana
Immunosuppression
Biological transport
Membrane proteins
cc-by-sa (c) Llaudó, I. et al., 2012
http://creativecommons.org/licenses/by-sa/3.0/es
Article
info:eu-repo/semantics/publishedVersion
Canadian Society for Pharmaceutical Sciences
         

Show full item record

Related documents

Other documents of the same author

Chiva Blanch, Gemma; Giménez Bonafé, Pepita; Llaudó Vallmajor, Inés; Torras Ambròs, Joan; Cruzado, Josep Ma.; Petriz, J.; Castaño Boldú, Esther; Franquesa, M.; Herrero Fresneda, Immaculada; Tortosa i Moreno, Avelina; Rama, I.; Bestard Matamoros, Oriol; Grinyo Boira, Josep M.; Lloberas Blanch, Núria
Ripoll Llagostera, Èlia; Merino, Ana; Gomà, Montse; Aran Perramon, Josep M.; Bolaños, Nuria; Ramon, Laura de; Herrero Fresneda, Immaculada; Bestard Matamoros, Oriol; Cruzado, Josep Ma.; Grinyo Boira, Josep M.; Torras Ambròs, Joan
Ripoll Llagostera, Èlia; Merino, Ana; Gomà, Montse; Aran Perramon, Josep M.; Bolaños, Nuria; Ramon, Laura de; Herrero Fresneda, Immaculada; Bestard Matamoros, Oriol; Cruzado, Josep Ma.; Grinyo Boira, Josep M.; Torras Ambròs, Joan
Kurdián, Melania; Herrero Fresneda, Immaculada; Lloberas Blanch, Núria; Giménez Bonafé, Pepita; Coria, Virginia; Grande, María T.; Boggia, José; Malacrida, Leonel; Torras Ambròs, Joan; Arévalo, Miguel A.; González-Martínez, Francisco; López-Novoa, José M.; Grinyo Boira, Josep M.; Noboa, Oscar
Cruzado, Josep Ma.; Moreno Llorente, Pablo; Torregrosa Prats, José Vicente; Taco, Omar; Mast, Richard; Gómez Vaquero, Carmen; Polo, Carolina; Revuelta, Ignacio; Francos Martínez, J. M.; Torras Ambròs, Joan; Gracia Barrasa, Arantxa; Bestard Matamoros, Oriol; Grinyo Boira, Josep M.
 

Coordination

 

Supporters